Aristotle Georgiou

Aristotle Georgiou is a leading UK hematologist specializing in the biology and clinical management of myelodysplastic syndromes. His research focuses on the molecular mechanisms driving ineffective erythropoiesis and clonal evolution in MDS. He has contributed to understanding how inflammation and bone marrow microenvironment dysfunction collaborate with somatic mutations to impair normal hematopoiesis. He leads clinical trials evaluating novel supportive care and disease-modifying strategies in MDS patients at various risk levels.